Lancashire and South Cumbria
Formulary
Formulary
13 Skin
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
13-02-01 Emollients - with antimicrobials
Links
LSCMMG: Gastroenterology Biologics Pathway- LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy
- LSCMMG: Primary Care Constipation Guidelines
- MHRA Drug Safety Update April 2016: Paraffin-based skin emollients on dressings or clothing: fire risk
- MHRA Drug Safety Update Aug 2020: Emollients and risk of severe and fatal burns: new resources available
- MHRA Drug Safety Update Dec 2018: Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
- MHRA: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people